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Assessing two spirometric criteria of pre-bronchodilator and post-bronchodilator
FEV1/FVC ratio in detecting air flow obstruction
Zeeshan Waheed, Muhammad Irfan, Ahmed Suleman Haque, Najmul Hasan Siddiqui,
Safia Awan, Beenish Syed, Javaid Ahmed Khan
Section of Pulmonary & Critical Care Medicine, Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan.
Abstract
Objectives: To assess the Pre-bronchodilator criteria and the Post-bronchodilator criteria of FEV1/FVC ratio in
diagnosing Airflow obstruction.
Methods: An observational study was conducted from 1988 to 2006 at the Aga Khan University Hospital.
Patients referred to the pulmonary function test laboratory for spirometry with bronchodilator reversibility at the
hospital during the above said period were enrolled. Forced spirometry was performed according to ATS
guidelines. All patients who had pre-bronchodilator criteria of airflow obstruction were analyzed and compared
with the post bronchodilator criteria. 
Results: A total of 4222 individuals underwent spirometry out of which 4072 individuals were studied.Using the
pre bronchodilator criteria, 1375 (34%) patients had airflow obstruction. Applying the post bronchodilator criteria
on the same patients, 1098 (27%) had evidence of airway obstruction. Out of these 1375 patients who had
airflow obstruction by using pre-bronchodilator criteria, 277 (20%) patients had no airflow obstruction by using
the post bronchodilator criteria. Out of these 277 patients, 52% had significant airways reversibility as evidenced
by >12% increase in their FEV1 pre and post bronchodilator.
Conclusion: Pre bronchodilator criteria for detection of airflow obstruction overestimate the diagnosis of airflow
obstruction and by using post bronchodilator criteria for airway obstruction on spirometry, decreases this over
diagnosis of the condition
Keywords: Spirometric criteria, Airflow obstruction, COPD, Asthma (JPMA 61: 1172; 2011).
Original Article
Introduction
Chronic Obstructive Pulmonary Disease (COPD)
ranks among the top five causes of death in developed
countries1 and it continues to increase its effect on morbidity
and mortality throughout the world.2,3 For the diagnosis and
assessment of COPD, spirometry is the gold standard as it is
the most reproducible, standardized, and objective way of
measuring airflow limitation. According to Global Initiative
for Chronic Obstructive Lung Disease (GOLD) COPD is
defined on spirometry as a post-bronchodilator ratio of
forced expiratory volume in one second (FEV1) to forced
vital capacity (FVC) < 0.7, and disease severity is
categorized based on post-bronchodilator forced expiratory
volume in one second (FEV1) in percent of predicted.4
The most important factor in the evaluation of
patients with COPD is to determine ventilatory limitation
accurately. Recent international guidelines have emphasized
the importance of post-bronchodilator lung function
measurements in the diagnosis and severity classification of
chronic obstructive pulmonary disease (COPD).4,5 The use
of post-bronchodilator spirometry facilitates the distinction
between fully reversible asthma and poorly reversible
COPD, and may lead to a reduction in misclassification of
individuals with reversible obstruction as COPD cases. The
prevalence of COPD using pre-bronchodilator values gives
an overestimation, especially among young adults.6,7 Few
studies have been published that have used post
bronchodilator GOLD criteria for COPD prevalence and
shows the overestimation rate of COPD using the pre-
bronchodilator criteria.8,9
There are major differences in diagnosing airflow
obstruction among expert groups10 which leads to widely
varying prevalence estimates of COPD.11 Therefore it
complicates the assessment of the burden of disease and
creates a diagnostic confusion and also confounds the
comparability of research studies.12
There had been different criteria used for the
diagnosis/assessments of airflow obstruction13 Viegi et al
demonstrated that the measured prevalence of COPD is
mainly dependent upon the criterion used to define airflow
obstruction.14
Misdiagnosis or Misclassification of airflow
obstruction potentially results not only in an individual
patient being misinformed and incorrectly educated
about their condition, but can also lead to incorrect
management. 
The objective of the study was to assess the Pre-
bronchodilator criteria and the Post-bronchodilator criteria
of FEV1/FVC ratio in diagnosing Airflow obstruction in our
setting.
Patients and Methods
An observational study was conducted from 1988 to
2006 at the Aga Khan University Hospital, Karachi.
All patients referred to the pulmonary function
laboratory for spirometry with bronchodilator reversibility
were enrolled. Information regarding patient demographics
and disease history, respiratory symptoms, occupational
exposure to airborne agents, and smoking history were
collected using a standardized Performa. 
Standing height and weight of the patients were
measured and body mass index (BMI) was categorized into
four groups: <20kg/m2, 20-24.9kg/m2, 25-29.9kg/m2 and
>30kg/m2.
Forced spirometry was performed according to
guidelines issued by American Thoracic Society (ATS).
Forced Vital Capacity (FVC) and Forced Expiratory Volume
in one second (FEV1) were measured with a spirometer
MedGraphics Profiler (Pulmonary diagnostic system by
Medical graphic Corporation, USA) according to the
American Thoracic Society (ATS) criteria.15,16 Spirometry
was performed before and 5 minutes after inhalation of 0.2
mg salbutamol inhaler (Made by GlaxoSmithKline) at room
temperature ranging from 19 to 24°C, with a mean of 22 ± 0.5
. Highest value for FVC and the highest value for FEV1 were
used in the ratio FEV1/FVC. 
The subject breathed in from room air and then
exhaled into the spirometer. The wedge opened as air was
blown into the spirometer, and a marker moved accordingly
along a sheet of paper for 6 seconds. 
Analysis:
For all patients who had pre bronchodilator criteria of
airflow obstruction FEV1/FVC of <0.7, values of FVC,
FEV1 and FEV1/FVC ratios were analyzed (both in pre-
bronchodilator and post-bronchodilators values were
examined).
Results
A total of 4222 individuals underwent spirometry in
the above said period. Of these 150 individuals failed to
perform spirometry effectively and were excluded from the
study, and remaining 4072 individuals were analyzed. The
mean age of the study population was 53.5 ± 16.3 years (range
15-95). Mean BMI was 26.3 ± 5.73 kg/m2. Symptomatically,
50% had cough and 70% had dyspnoea. The base line
characteristics of the patients are given in Table-1. 
Out of 4072 individuals who underwent spirometry
with bronchodilator reversibility testing; using the pre
bronchodilator criteria, 1374 (34%) had airflow
obstruction. Applying the post bronchodilator criteria on
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the same group of patients, 1098 (27%) had evidence of
airway obstruction.
Out of these 1375 patients who had airflow
obstruction by using pre-bronchodilator criteria, 277 (20%)
had no airflow obstruction by using the post bronchodilator
criteria. Out of these 277 patients, 52% had significant
airways reversibility as evidenced by >12% increase in their
FEV1 pre and post bronchodilator (Table-2).
Discussion
Several guidelines have been in use for diagnosing
and finding the severity of the of airflow obstruction in
COPD. The Global Initiative for Chronic Obstructive Lung
Disease (GOLD) and American Thoracic Society
(ATS)/European Respiratory Society (ERS) criteria for
defining COPD are quite different in several aspects.
GOLD committee defines airway obstruction as an
FEV1/FVC < 70% after post bronchodilator spirometry
while ATS/ERS guidelines set post bronchodilator values
of FEV1/FVC < 5th percentile for diagnosing the COPD.17
Before the establishment of GOLD guidelines several
studies have reported airflow obstruction in COPD patients
by using pre-bronchodilator testing.18,19 The major flaw of
using the pre-bronchodilator spirometry values for
diagnosing the airflow obstruction was that the people with
reversible airflow obstruction were not excluded. All the
previous publications have shown that both prevalence and
incidence of COPD in a general population decreased
substantially when COPD was defined with post-
bronchodilator rather than pre-bronchodilator lung function
values,7,9 likewise our study also showed the same findings
that is 1375 (34% of all individuals) had air flow
obstruction using the pre-bronchodilator spirometry which
was significantly higher than 1098 (27% of all individuals)
who had air flow obstruction using the post-bronchodilator
spirometry i.e., a total of 277 (20% of individuals who had
pre-bronchodilator airflow obstruction) were excluded
from the category of airflow obstruction after
bronchodilation.
Recently, a community study in Norway reported
that the prevalence of airflow obstruction in subjects with
bronchodilation was 27% lower than that defined without
bronchodilation (7.7%)7 as in our study in which
bronchodilation lowered the prevalence of airflow
limitation by 20% compared to the value without
bronchodilation.
Similarly, a study on Korean population by Kim et al
showed that COPD prevalence by post-bronchodilator
GOLD criteria was 3.7%, which was much lower than that
of pre-bronchodilator criteria.9 These results imply that the
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Table-1: Characteristics of study population.
Women (%) Men (%) N (%)
(N=1569, 38.5%) (N=2503, 61.5%) (4072, 100%)
Age (Years)
15-29 183(12) 224(9) 407(10)
29-44 298(19) 446(18) 744(18)
45-59 559(36) 722(29) 1281(31)
60-74 431(27) 849(34) 1280(31)
>74 98(6) 262(10) 360(9)
Body mass Index 
(kg/m2)
<20 167(11) 318(13) 485(12)
20-24.9 377(24) 857(34) 1234(30)
25-29.9 531(34) 926(37) 1457(36)
>30 494(31) 402(16) 896(22)
Mean Height (cm) 153.3 ± 7.9 167.5 ± 44.5 162.0 ± 36.7
Mean Weight (Kg) 65.0 ± 16.3 71.70 ± 18.4 69.1 ± 17.9
Table-2: Airflow Obstruction (FEV1 /FVC <70%) defined before and after bronchodilation.
Variables Numbers (n) Pre-BD Airflow Post- BD Airflow Percentage of reduction in
Obstruction Obstruction Airflow Obstruction
Total Patients 4072 1375 1098 20%
Sex
Female 1569 366 252 31%
Male 2503 1009 846 16%
Age (years)
15-29 407 79 40 49%
30-44 744 163 115 29%
45-59 1281 383 307 20%
60-74 1280 582 496 15%
>74 360 168 140 17%
BMI (kg/m2)
<20 485 217 192 12%
20-24.9 1234 509 419 18%
25-29.9 1457 448 349 22%
>30 896 201 138 31%
pre-bronchodilator COPD criteria overestimate the
diagnosis of airflow obstruction and also, that many people
may have been erroneously diagnosed as COPD and
undergone unnecessary, inappropriate medical
examinations and treatment.
Conclusion
The study concluded that the diagnosis of airflow
obstruction depends on the criteria used for airway
obstruction. Pre bronchodilator criteria for detection of
airflow obstruction overestimate the diagnosis of airflow
obstruction and by using post bronchodilator criteria for
airway obstruction on spirometry decreases this over
diagnosis of the condition.
Finally, it is recommended that more studies should be
carried out to find out the predictive value of spirometry in
the diagnosis of COPD and to establish both post-
bronchodilator prediction equations and reversibility
prediction equations and their implementation.
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